Tecnología Médica

Tecnología Médica

Abbott’s Tendyne TMVR System Receives FDA Approval: The Future of Heart Valve Replacement
29/05/2025 - Abbott’s Tendyne TMVR System has received FDA approval, offering a minimally invasive solution for patients with severe mitral annular calcification who aren’t eligible for open-heart...
Minimally Invasive Heart Surgery: Can TAVI & TMVr Replace Open Surgery for Good?
21/04/2025 - Minimally invasive heart surgery is redefining how heart conditions are managed, offering safer, faster alternatives to open-heart procedures. Two major innovations leading this shift are...
What’s next for Capstan Medical after their first-in-human robot-assisted transcatheter heart valve replacement
07/04/2025 - Capstan Medical is developing novel mitral and tricuspid heart valves, as well as robot-assisted catheter delivery technology for minimally invasive implantation. [Photo courtesy of Capstan...
Teleflex adquirirá el negocio de intervención vascular de BIOTRONIK
31/03/2025 - Teleflex (Wayne, PA, EUA) ha firmado un acuerdo definitivo para adquirir prácticamente la totalidad del negocio de intervención vascular de BIOTRONIK (Berlín, Alemania) por un...
Why V-Wave’s heart failure tech is worth $1.7B to Johnson & Johnson
22/08/2024 - Cardiac implant developer V-Wave has a deal to be acquired by Johnson & Johnson for $600 million upfront, plus up to $1.1 billion in additional payments based on regulatory and commercial...
Edwards Lifesciences adquiere Innovalve Bio Medical de Sheba Medical
29/07/2024 - Edwards Lifesciences (Irvine, CA, EUA), una empresa líder en innovaciones médicas para enfermedades estructurales del corazón y cuidados críticos, ha adquirido...
InnovHeart’s Groundbreaking TMVr Procedure Achieves Remarkable Success: SATURN Valve
10/06/2024 - The field of transcatheter mitral valve repair (TMVr) has reached an exciting milestone with InnovHeart’s recent announcement. Their SATURN transcatheter mitral valve has demonstrated...
Abbott’s FDA Approval Revolutionizes Treatment for Peripheral Vascular Disease with Esprit™ BTK System
02/05/2024 - Abbott Laboratories has made a significant breakthrough in the treatment of chronic limb-threatening ischemia (CLTI) with its recent FDA approval of the Esprit™ BTK Everolimus Eluting...
Ventricular Assist Device and Intra-Aortic Balloon Pump Device Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore | Includes: Percutaneous VAD Market, Implantable VAD Market, IABP Catheter Market and IABP Console Market
30/04/2024 - Ventricular assist devices (VADs) are used to aid a failing heart by supplementing the pumping function of the heart. VADs are often used in patients with advanced heart failure (HF). HF...
CroíValve’s Duo takes a unique approach for treating tricuspid regurgitation
29/04/2024 - CroíValve is making inroads in the tricuspid regurgitation (TR) treatment market currently occupied by Abbott and Edwards. In February 2024, Edwards’ Evoque tricuspid valve...
Annuloplasty Market Size, Share and Trends Analysis | Global | 2024-2030 | MedCore
22/04/2024 - Overall, the global annuloplasty repair device market was valued at $238 million in 2023. This is expected to increase over the forecast period at a CAGR of 2.0% to reach $274...
Transcatheter Heart Valve Replacement Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore |
22/04/2024 - Overall, the global transcatheter heart valve replacement market was valued at $7 billion in 2023. This is expected to increase over the forecast period at a CAGR of 6.8% to reach...
Cardiac Surgery Market Size, Share & Trends Analysis | Global | 2024-2030 | MedSuite | Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 20 more
16/04/2024 - Overall, the global cardiac surgery device market was valued at $17.1 billion in 2023. This is expected to increase over the forecast period at a CAGR of 5.5% to reach $24.9...
Tissue Heart Valve Market Analysis | Global | 2024-2030 | MedCore | Segmented by: Stented Tissue Heart Valves, Stentless Tissue Heart Valves, and 1 more
16/04/2024 - The global Heart Defects Closure Device Market Reportcontains analysis for Patent Foramen Ovale Closure Devices and Atrial & Ventricular Septal Defect Closure Devices. The global patent...
Mechanical Heart Valve Market Analysis | Global | 2024-2030 | MedCore
16/04/2024 - Overall, the global mechanical heart valve market was valued at $197 million in 2023. This is expected to decrease at a CAGR of -2% to $171 million over the forecast...
Edwards’ EVOQUE Valve Greenlit by FDA for Transcatheter Therapy
07/03/2024 - In a groundbreaking move, Edwards Lifesciences Corporation has achieved a monumental milestone in transcatheter therapy. Their EVOQUE tricuspid valve replacement system has become the first of its...
FDA removes dialysis-related products from device shortage list
06/03/2024 - The FDA has removed two dialysis-related product codes from its device shortage list. The products — kidney perfusion system (product code KDN) and disposable kidney perfusion set...
Over 290,000 Heart Valve Replacements Per Year in the United States by 2029
06/03/2024 - According to the latest Cardiac Surgery market study, on average, over 100,000 heart valve replacements were performed every year in the United States between 2019-2023. These replacements are one...
Cardiac Surgery Market Size, Share, and Trends Analysis | Europe | 2024-2030 | MedSuite | Includes: Tissue Heart Valves, Mechanical Heart Valves, and 20 more
23/01/2024 - Overall, the European cardiac surgery market was valued at €2.9 billion in 2023. This is expected to increase over the forecast period at a CAGR of 3.4% to reach nearly €3.7...
Percutaneous Transluminal Angioplasty (PTA) Balloon Market Size, Share & Analysis | Global | 2024-2030 | MedCore | Segmented By Device Type
13/11/2023 - Overall, the global percutaneous transluminal angioplasty balloon market was valued at $539 million in 2023. This is expected to increase over the forecast period at a...
Stent Graft Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore | Includes: AAA, FAA, TAA Stent Graft Markets
13/11/2023 - Overall, the global stent graft market was valued at $2.7 billion in 2023. This is expected to increase over the forecast period at a CAGR of 4.9% to reach...